SCHEMBL3584616

SCHEMBL3584616

NC1CC12CCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9566395 1.00
SCHEMBL9566469 1.00
SCHEMBL9566390 1.00
SCHEMBL9566372 1.00
SCHEMBL12274704 1.00
Hydrochloric Acid SCHEMBL9566502 0.97
Hydrochloric Acid SCHEMBL9566367 0.97
Hydrochloric Acid SCHEMBL9566377 0.97
Bromide SCHEMBL9572069 0.97
Hydrochloric Acid SCHEMBL9566386 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550025-A1 Azaspiroheptanes and octanes and processes for their production KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1993-07-07 EP claimed
JP-7300460-A None JP disclosed
WO-2021262426-A2 ADAMANTANE AMIDES AND THIOAMIDES FOR THE TREATMENT OF EBOLAVIRUS INFECTION ARISAN THERAPEUTICS INC. (US) 2021-12-30 WO disclosed
WO-2020150372-A1 ANTIMICROBIAL COMPOUNDS AND METHODS CURZA GLOBAL, LLC (US) 2020-07-23 WO disclosed
US-20200187502-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-06-18 US disclosed
WO-2018162643-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2018-09-13 WO disclosed
EP-2686320-B1 TRICYCLIC GYRASE INHIBITORS MERCK SHARP & DOHME (US) 2016-05-18 EP disclosed
WO-2012125746-A1 TRICYCLIC GYRASE INHIBITORS TRIUS THERAPEUTICS INC. (US) 2012-09-20 WO disclosed
WO-2011032050-A2 GYRASE INHIBITORS TRIUS THERAPEUTICS, INC. (US) 2011-03-17 WO disclosed
US-20100069435-A1 METHOD OF SELECTIVELY INTRODUCING AMINO SUBSTITUENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2010-03-18 US disclosed
US-7626029-B2 Into a difluorobenzoic acid, for producting quinolonecarboxylic acid serving as synthetic antibacterial agent, medicament, agricultural chemical, or veterinary drug; ionic liquid solvents DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-12-01 US disclosed
US-20060122396-A1 Method of selectively introducing amino substituent DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-06-08 US disclosed
EP-1634879-A1 METHOD OF SELECTIVELY INTRODUCING AMINO SUBSTITUENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-03-15 EP disclosed
EP-0816355-B1 HETEROCYCLIC SPIRO DERIVATIVES DAIICHI SEIYAKU CO (JP) 2003-05-14 EP disclosed
US-6469023-B1 QUINOLONE DERIVATIVE HAVING A 1-AMINO-5- AZABISPIRO(2.4)HEPTYL GROUP AT THE 7-POSITION AND A HALOGENOCYCLOPROPYL GROUP AT THE 1-POSITION; AN ANTIBACTERIAL COMPOUND USEFUL AS MEDICINES, ANIMAL DRUGS, FISHERIES DRUGS OR ANTIBACTERIAL PRESERVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-10-22 US disclosed
EP-0816355-A1 HETEROCYCLIC SPIRO DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-01-07 EP disclosed
JP-H07300460-A NEW AZASPIRO DERIVATIVE AND ITS PRODUCTION KOREA RES INST CHEM TECHNOL 1995-11-14 JP disclosed
EP-0550016-A1 Novel quinolone carboxylic acid derivatives and processes for preparing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1993-07-07 EP disclosed
EP-0550025-A1 Azaspiroheptanes and octanes and processes for their production KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1993-07-07 EP disclosed